Skip to main content
    C

    CVS Health Corp (CVS)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $88.60
    -0.75 (-0.84%)

    Market Cap: $114.32B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CVS Health Corp (CVS) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    CVS Health (CVS) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, CVS Health reported EPS of $2.09, above the $1.62 estimate. It beat the EPS estimate in each of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +9.70%
    Streak
    8 Q

    Upcoming Estimates

    Reports Feb 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.07
    Range$0.95 - $1.34
    26 analysts
    Revenue Consensus
    $109.01B
    Range$102.98B - $121.55B
    22 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$2.74
    Range$2.53 - $2.93
    12 analysts
    EPS Revisions
    2
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$2.71+1.3%
    60d ago$2.69+1.9%
    30d ago$2.69+2.2%
    7d ago$2.74+0.3%
    Current$2.74
    Revenue Consensus
    $101.91B
    Range$97.89B - $104.42B
    7 analysts

    Next Report

    CVS has an expected report date of Feb 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 1.8% below the $1.09 reported for the quarter ended Dec 31, 2025.

    CVS Earnings Call

    The latest CVS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CVS beat 38 and missed 2. Revenue for the quarter ended Sep 30, 2026 was $108.40B, up 5.4% from $102.87B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.09$1.62$1.52 - $1.87+29.01%Beat+30.6%235 up, 1 downNov 4, 2026$108.40B
    Jun 30, 2026$2.58$1.87$1.58 - $1.94+37.97%Beat+42.5%233 up, 0 downAug 5, 2026$106.10B
    Mar 31, 2026$2.57$2.21$2.10 - $2.38+16.29%Beat+14.2%223 up, 11 downMay 6, 2026$100.43B
    Dec 31, 2025$1.09$1.00$0.93 - $1.08+9.00%Beat-8.4%242 up, 0 downFeb 10, 2026$105.69B
    Sep 30, 2025$1.60$1.36$1.23 - $1.53+17.65%Beat+46.8%243 up, 4 downOct 29, 2025$102.87B
    Jun 30, 2025$1.81$1.46$1.35 - $1.72+23.97%Beat-1.1%233 up, 2 downJul 31, 2025$98.92B
    Mar 31, 2025$2.25$1.67$1.41 - $1.91+34.73%Beat+71.8%223 up, 1 downMay 1, 2025$94.59B
    Dec 31, 2024$1.19$0.92$0.45 - $1.09+29.35%Beat-43.9%230 up, 5 downFeb 12, 2025$97.71B
    Sep 30, 2024$1.09$1.46$1.05 - $1.99-25.34%Miss-50.7%220 up, 1 downNov 6, 2024$95.43B
    Jun 30, 2024$1.83$1.73$1.60 - $2.02+5.78%Beat-17.2%220 up, 1 downAug 7, 2024$91.23B
    Mar 31, 2024$1.31$1.70$1.62 - $1.99-22.94%Miss-40.5%220 up, 3 downMay 1, 2024$88.44B
    Dec 31, 2023$2.12$1.99N/A+6.53%Beat+6.5%196 up, 1 downFeb 7, 2024$93.81B
    Sep 30, 2023$2.21$2.13$2.01 - $2.21+3.76%Beat+2.8%202 up, 0 downNov 1, 2023$89.76B
    Jun 30, 2023$2.21$2.12$1.91 - $2.40+4.25%Beat-7.9%223 up, 1 downAug 2, 2023$88.92B
    Mar 31, 2023$2.20$2.09$1.92 - $2.19+5.26%Beat-0.9%213 up, 1 downMay 3, 2023$85.28B
    Dec 31, 2022$1.99$1.93$1.89 - $1.96+3.11%Beat+0.5%196 up, 0 downFeb 8, 2023$83.85B
    Sep 30, 2022$2.15$1.99$1.92 - $2.08+8.04%Beat+9.1%213 up, 0 downNov 2, 2022$81.16B
    Jun 30, 2022$2.40$2.18$2.10 - $2.37+10.09%Beat-0.8%233 up, 0 downAug 3, 2022$80.64B
    Mar 31, 2022$2.22$2.15$1.97 - $2.41+3.26%Beat+8.8%202 up, 1 downMay 4, 2022$76.83B
    Dec 31, 2021$1.98$1.88N/A+5.32%Beat+52.3%15N/AFeb 9, 2022$76.60B
    Sep 30, 2021$1.97$1.79$1.69 - $1.93+10.06%Beat+18.7%22N/ANov 3, 2021$73.79B
    Jun 30, 2021$2.42$2.07$1.85 - $2.24+16.91%Beat-8.3%22N/AAug 4, 2021$72.62B
    Mar 31, 2021$2.04$1.72$1.49 - $1.80+18.60%Beat+6.8%22N/AMay 4, 2021$69.10B
    Dec 31, 2020$1.30$1.24$1.17 - $1.40+4.84%Beat-24.9%23N/AFeb 16, 2021$69.55B
    Sep 30, 2020$1.66$1.34$1.24 - $1.39+23.88%Beat-9.8%25N/ANov 6, 2020$67.06B
    Jun 30, 2020$2.64$1.92$1.66 - $2.17+37.50%Beat+39.7%23N/AAug 5, 2020$65.34B
    Mar 31, 2020$1.91$1.63$1.54 - $1.78+17.18%Beat+17.9%22N/AMay 6, 2020$66.75B
    Dec 31, 2019$1.73$1.69$1.65 - $1.75+2.37%Beat-19.2%24N/AFeb 12, 2020$66.89B
    Sep 30, 2019$1.84$1.77$1.75 - $1.79+3.95%Beat+6.4%24N/ANov 6, 2019$64.81B
    Jun 30, 2019$1.89$1.69$1.68 - $1.71+11.83%Beat+11.8%24N/AAug 7, 2019$63.43B
    Mar 31, 2019$1.62$1.51$1.43 - $1.63+7.28%Beat+9.5%23N/AMay 1, 2019$61.65B
    Dec 31, 2018$2.14$2.05$1.84 - $2.22+4.39%Beat+11.5%12N/AFeb 20, 2019$54.42B
    Sep 30, 2018$1.73$1.71$1.69 - $1.78+1.17%Beat+15.3%21N/ANov 6, 2018$47.49B
    Jun 30, 2018$1.69$1.61$1.59 - $1.65+4.97%Beat+27.1%19N/AAug 8, 2018$46.92B
    Mar 31, 2018$1.48$1.41$1.27 - $1.48+4.96%Beat+26.5%21N/AMay 2, 2018$45.74B
    Dec 31, 2017$1.92$1.88$1.87 - $1.92+2.13%Beat+12.3%22N/AFeb 8, 2018$48.41B
    Sep 30, 2017$1.50$1.49$1.47 - $1.51+0.67%Beat-8.5%21N/ANov 6, 2017$46.18B
    Jun 30, 2017$1.33$1.31$1.29 - $1.33+1.53%Beat+0.8%23N/AAug 8, 2017$45.69B
    Mar 31, 2017$1.17$1.10N/A+6.36%Beat-0.8%N/AN/AMay 2, 2017$44.51B
    Dec 31, 2016$1.71$1.67N/A+2.40%Beat+11.8%N/AN/AFeb 9, 2017$45.99B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $6.75, up 24.5% from the year before. It was $5.85 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$6.75+24.5%
    Dec 31, 2024$5.42-38.0%
    Dec 31, 2023$8.74N/A
    Dec 31, 2022$8.76+4.2%
    Dec 31, 2021$8.41+12.0%
    Dec 31, 2020$7.51+6.1%
    Dec 31, 2019$7.08N/A
    Dec 31, 2018$7.04+18.9%
    Dec 31, 2017$5.92+1.2%
    Dec 31, 2016$5.85N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,16317
    2026Q2Jun 30, 20267,74513
    2026Q1Mar 31, 20268,67414
    2025Q4Dec 31, 20258,24717
    2025Q3Sep 30, 20258,36014
    2025Q2Jun 30, 20257,89515
    2025Q1Mar 31, 20258,73314
    2024Q4Dec 31, 20249,12913

    2026Q3 Earnings Call

    Opening remarks

    Larry McGrath Executive Vice President of Capital Markets Good morning, and welcome to the CVS Health Third Quarter 2026 Earnings and Business Update Call and Webcast. I am Larry McGrath, executive vice president of capital markets at CVS Health. I am joined this morning by David Joyner, Chairman and Chief Executive Officer, and Brian O. Newman, Chief Financial Officer. Following our prepared remarks, we will host a question-and-answer session that will include additional members of the leadership team. Our press releases and slide presentations have been posted to our website, along with our Form 10-Q filed this morning with the SEC. Today's call is also being broadcast on our website. During this call, we will make certain forward-looking statements. Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties, in particular those described in the cautionary statement concerning forward-looking statements and risk factors in our most recent annual report on Form 10-K, our quarterly report on Form 10-Q filed this morning, and our recent filings on Form 8-K, including this morning's earnings press release. During this call, we will use certain non-GAAP measures when talking about the company's financial performance and financial condition. You can find a reconciliation of these non-GAAP measures in this morning's press release and in the reconciliation document posted to the Investor Relations portion of our website. With that, I would like to turn the call over to David. David?

    J. David Joyner Chairman and Chief Executive Officer Thank you, Larry, and good morning, everyone. Our organization has a long and distinguished history, and in my 40 years at this company, there has been one constant: We act, we evolve, and we proactively shape the future of health care. Today, we announced our intention to separate into two independent publicly traded companies. This decision marks the next important chapter in the evolution of CVS Health. We are creating two distinct leaders in health care. The first will be a health care solutions company that brings together medical, pharmacy, specialty, and care delivery capabilities, integrated where it matters. In the interim period, we are referring to this business as CVS Health. The second company will be a leading national retail pharmacy and community health care company. This business will be named CVS Pharmacy. Both companies will be led by experienced leadership teams, have a clear right to win in their respective markets, and, we expect, will be supported by solid investment-grade balance sheets, enabling each company to pursue disciplined and tailored capital allocation.

    Frequently Asked Questions About CVS

    When is CVS Health's next earnings date?

    CVS Health's next earnings report is expected for Feb 8, 2027.

    Did CVS beat earnings estimates last quarter?

    Yes. CVS Health reported EPS of $2.09 for the quarter ended Sep 30, 2026, above the $1.62 estimate, a 29.01% surprise.

    What EPS do analysts expect from CVS next quarter?

    The consensus EPS estimate for CVS Health for the quarter ending Dec 31, 2026 is $1.07 from 26 analysts, with estimates from $0.95 to $1.34.

    How often does CVS beat earnings estimates?

    CVS Health beat the EPS estimate in each of the last 8 quarters, with an average surprise of +24.75%.